2,760
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Novel CD123-aptamer-originated targeted drug trains for selectively delivering cytotoxic agent to tumor cells in acute myeloid leukemia theranostics

, , , , , , , , , & show all
Pages 1216-1229 | Received 22 Jun 2017, Accepted 11 Aug 2017, Published online: 28 Aug 2017

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.